tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LYRA Stock Latest News

One new option listing and option delistings on January 20th
The FlyOne new option listing and option delistings on January 20th
12d ago
CVM
TEF
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
20d ago
AMD
ANF
Why Is Lyra Therapeutics Stock (LYRA) Down Today?
PremiumMarket News
Why Is Lyra Therapeutics Stock (LYRA) Down Today?
20d ago
LYRA
Lyra Therapeutics Halts LYR-210, Cuts Workforce, Explores Options
PremiumCompany Announcements
Lyra Therapeutics Halts LYR-210, Cuts Workforce, Explores Options
20d ago
8K
LYRA
Lyra Therapeutics suspends further development of LYR-210
PremiumThe Fly
Lyra Therapeutics suspends further development of LYR-210
20d ago
LYRA
Cautious Hold Rating for Lyra Therapeutics Amid Strategic Focus and Financial Challenges
PremiumRatingsCautious Hold Rating for Lyra Therapeutics Amid Strategic Focus and Financial Challenges
3M ago
LYRA
Lyra Therapeutics Faces Financial Challenges Amid Clinical Setbacks
Premium
Company Announcements
Lyra Therapeutics Faces Financial Challenges Amid Clinical Setbacks
3M ago
LYRA
Lyra Therapeutics reports Q3 EPS ($3.38), consensus ($4.07)
Premium
The Fly
Lyra Therapeutics reports Q3 EPS ($3.38), consensus ($4.07)
3M ago
LYRA
LYRA Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
LYRA Upcoming Earnings Report: What to Expect?
3M ago
LYRA
Lyra Therapeutics announces clinical plan for LYR-210
PremiumThe Fly
Lyra Therapeutics announces clinical plan for LYR-210
4M ago
LYRA
Lyra Therapeutics Posts Corporate Presentation on LYR-210
PremiumCompany Announcements
Lyra Therapeutics Posts Corporate Presentation on LYR-210
5M ago
8K
LYRA
Lyra Therapeutics Receives Nasdaq Deficiency Letter
PremiumCompany Announcements
Lyra Therapeutics Receives Nasdaq Deficiency Letter
5M ago
8K
LYRA
Cautious Hold Rating on Lyra Therapeutics Amid Uncertainty in LYR-210’s Development and Approval Prospects
PremiumRatingsCautious Hold Rating on Lyra Therapeutics Amid Uncertainty in LYR-210’s Development and Approval Prospects
6M ago
LYRA
Lyra Therapeutics Faces Manufacturing and Staffing Challenges Amid LYR-210 Production Shift
Premium
Company Announcements
Lyra Therapeutics Faces Manufacturing and Staffing Challenges Amid LYR-210 Production Shift
6M ago
LYRA
Lyra Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Lyra Therapeutics Reports Q2 2025 Financial Results
6M ago
LYRA
Lyra Therapeutics reports Q2 EPS ($5.51), consensus ($4.78)
PremiumThe Fly
Lyra Therapeutics reports Q2 EPS ($5.51), consensus ($4.78)
6M ago
LYRA
Is LYRA a Buy, Before Earnings?
PremiumPre-Earnings
Is LYRA a Buy, Before Earnings?
6M ago
LYRA
Lyra Therapeutics Announces Leadership Changes in August 2025
PremiumCompany Announcements
Lyra Therapeutics Announces Leadership Changes in August 2025
6M ago
8K
LYRA
Lyra Therapeutics files to sell 846,744 shares of common stock for holders
PremiumThe Fly
Lyra Therapeutics files to sell 846,744 shares of common stock for holders
6M ago
LYRA
Lyra Therapeutics Secures $4.3M in Direct Offering
PremiumCompany AnnouncementsLyra Therapeutics Secures $4.3M in Direct Offering
7M ago
8K
LYRA
Lyra Therapeutics Regains Nasdaq Compliance in June 2025
Premium
Company Announcements
Lyra Therapeutics Regains Nasdaq Compliance in June 2025
7M ago
8K
LYRA
Lyra Therapeutics target adjusted to $16 from $2 at H.C. Wainwright
Premium
The Fly
Lyra Therapeutics target adjusted to $16 from $2 at H.C. Wainwright
8M ago
LYRA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >